The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clarithromycin 500 mg Powder for concentrate for solution for infusion

500 milligram(s) Powder for concentrate for solution for infusion

Noridem Enterprises LtdPA1122/025/001

Main Information

Trade NameClarithromycin 500 mg Powder for concentrate for solution for infusion
Active SubstancesClarithromycin lactobionate
Strength500 milligram(s)
Dosage FormPowder for concentrate for solution for infusion
Licence HolderNoridem Enterprises Ltd
Licence NumberPA1122/025/001

Group Information

ATC CodeJ01FA09 clarithromycin

Status

Authorised/WithdrawnAuthorised
Licence Issued22/03/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back